131 related articles for article (PubMed ID: 27086936)
1. Rubinstein-Taybi syndrome - a window into follicular lymphoma biology.
Mar N; Digiuseppe JA; Dailey ME
Leuk Lymphoma; 2016 Dec; 57(12):2908-2910. PubMed ID: 27086936
[No Abstract] [Full Text] [Related]
2. Extraparotidal low grade follicular lymphoma associated with primary Sjögren's syndrome.
Gómez-Rubio J; Bárcena-Atalaya AB; Ruiz-Irastorza G
Med Clin (Barc); 2018 Mar; 150(5):204-205. PubMed ID: 28865918
[No Abstract] [Full Text] [Related]
3. Subcutaneous rituximab and chemotherapy achieves similar overall response rates to intravenous rituximab in first-line follicular lymphoma: efficacy and safety results of the phase III SABRINA study.
Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):6-7. PubMed ID: 25768992
[No Abstract] [Full Text] [Related]
4. Rubinstein-Taybi syndrome: clinical and molecular overview.
Roelfsema JH; Peters DJ
Expert Rev Mol Med; 2007 Aug; 9(23):1-16. PubMed ID: 17942008
[TBL] [Abstract][Full Text] [Related]
5. Something old, something few, something subjective, something déjà vu.
Horning SJ
J Clin Oncol; 2003 Jan; 21(1):1-2. PubMed ID: 12506161
[No Abstract] [Full Text] [Related]
6. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.
Kumar R; Galardy PJ; Dogan A; Rodriguez V; Khan SP
Pediatr Blood Cancer; 2011 Aug; 57(2):317-20. PubMed ID: 21462303
[TBL] [Abstract][Full Text] [Related]
7. Rubinstein-Taybi syndrome predisposing to non-WNT, non-SHH, group 3 medulloblastoma.
Bourdeaut F; Miquel C; Richer W; Grill J; Zerah M; Grison C; Pierron G; Amiel J; Krucker C; Radvanyi F; Brugieres L; Delattre O
Pediatr Blood Cancer; 2014 Feb; 61(2):383-6. PubMed ID: 24115570
[TBL] [Abstract][Full Text] [Related]
8. Rubinstein-Taybi syndrome and Hirschsprung disease in a patient harboring an intragenic deletion of the CREBBP gene.
Isidor B; Podevin G; Camby C; Mosnier JF; Chauty A; Lyet JM; Fergelot P; Lacombe D; Arveiler B; Pelet A; Amiel J; David A
Am J Med Genet A; 2010 Jul; 152A(7):1847-8. PubMed ID: 20583168
[No Abstract] [Full Text] [Related]
9. A novel mutation c.4003 G>C in the CREBBP gene in an adult female with Rubinstein-Taybi syndrome presenting with subtle dysmorphic features.
Li C; Szybowska M
Am J Med Genet A; 2010 Nov; 152A(11):2939-41. PubMed ID: 20949605
[No Abstract] [Full Text] [Related]
10. Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.
Taskinen M; Valo E; Karjalainen-Lindsberg ML; Hautaniemi S; Meri S; Leppä S
Clin Cancer Res; 2010 May; 16(9):2615-23. PubMed ID: 20388848
[TBL] [Abstract][Full Text] [Related]
11. [Primary cutaneous follicle centre lymphoma: report of a case].
Rong YF; He LM; Zhang YS; Feng YZ
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):769-70. PubMed ID: 24447559
[No Abstract] [Full Text] [Related]
12. Rituximab, interferon-alfa-2b and dose dense CVP is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the LNH-PRO-05 study.
Cannata-Ortiz J; Nicolás C; García-Noblejas A; Requena MJ; López-Jiménez J; Alaez Uson C; Arranz R
Br J Haematol; 2019 Jul; 186(1):168-170. PubMed ID: 30656671
[No Abstract] [Full Text] [Related]
13. Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study.
Tilly H; Morschhauser F; Casasnovas O; Molina TJ; Feugier P; Gouill SL; Haioun C; Tournilhac O; Bouabdallah R; Gabarre J; Lamy T; Cabeçadas J; Becker S; Jardin F; Mounier N; Salles G;
Lancet Haematol; 2018 Sep; 5(9):e403-e410. PubMed ID: 30172345
[TBL] [Abstract][Full Text] [Related]
14. Letter to the Editor: A Novel Mutation in the CREBBP Gene of a Korean Girl with Rubinstein-Taybi syndrome.
Huh R; Cho SY; Kim J; Ki CS; Jin DK
Ann Clin Lab Sci; 2015; 45(4):458-61. PubMed ID: 26275701
[TBL] [Abstract][Full Text] [Related]
15. Rubinstein-Taybi syndrome with multiple pilomatricomas: The first case diagnosed by CREBBP mutation analysis.
Rokunohe D; Nakano H; Akasaka E; Toyomaki Y; Sawamura D
J Dermatol Sci; 2016 Sep; 83(3):240-2. PubMed ID: 27342041
[No Abstract] [Full Text] [Related]
16. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
Watanabe T; Tobinai K; Wakabayashi M; Morishima Y; Kobayashi H; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Yoshino T; Nawano S; Terauchi T; Hotta T; Nagai H; Tsukasaki K;
Lancet Haematol; 2018 Nov; 5(11):e520-e531. PubMed ID: 30389034
[TBL] [Abstract][Full Text] [Related]
17. Management of patients with low-grade follicular lymphoma.
Cabanillas FF
Am J Clin Oncol; 1989 Feb; 12(1):81-7. PubMed ID: 2463754
[No Abstract] [Full Text] [Related]
18. Counterpoint: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
Barr PM
Oncology (Williston Park); 2018 Aug; 32(8):404, 407-9. PubMed ID: 30153320
[No Abstract] [Full Text] [Related]
19. Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma.
Dakhil S; Hermann R; Schreeder MT; Gregory SA; Monte M; Windsor KS; Hurst D; Chai A; Brewster M; Richards P
Leuk Lymphoma; 2014 Oct; 55(10):2335-40. PubMed ID: 24471908
[TBL] [Abstract][Full Text] [Related]
20. Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Watanabe R; Tomita N; Kishimoto K; Koyama S; Ogusa E; Ishii Y; Miyashita K; Matsuura S; Fujisawa S; Hattori Y; Takasaki H; Fujita A; Ohshima R; Kuwabara H; Hashimoto C; Fujimaki K; Sakai R; Ishigatsubo Y
Leuk Res; 2013 Oct; 37(10):1208-12. PubMed ID: 23927994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
